SG Americas Securities
FLGT icon

SG Americas Securities’s Fulgent Genetics FLGT Stock Holding History

SG Americas Securities’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,356
Closed -$292K – 3467
2026
Q1 		$292K Buy
18,356
+14
+0.1% +$304 ﹤0.01% 2469
2025
Q4 		$482K Sell
18,342
-825
-4% -$21.4K ﹤0.01% 2519
2025
Q3 		$433K Buy
+19,167
New +$395K ﹤0.01% 2222
2025
Q2 		– Sell
-14,769
Closed -$250K – 3158
2025
Q1 		$250K Buy
14,769
+2,251
+18% +$38.3K ﹤0.01% 2368
2024
Q4 		$231K Sell
12,518
-4,934
-28% -$96.3K ﹤0.01% 2015
2024
Q3 		$379K Buy
17,452
+4,626
+36% +$103K ﹤0.01% 1940
2024
Q2 		$252K Buy
12,826
+3,425
+36% +$71.5K ﹤0.01% 2054
2024
Q1 		$204K Sell
9,401
-2,862
-23% -$71.1K ﹤0.01% 1958
2023
Q4 		$355K Sell
12,263
-20,839
-63% -$558K ﹤0.01% 1691
2023
Q3 		$885K Buy
33,102
+24,451
+283% +$835K 0.01% 1372
2023
Q2 		$320K Sell
8,651
-14,313
-62% -$499K ﹤0.01% 1586
2023
Q1 		$717K Sell
22,964
-23,469
-51% -$755K 0.01% 1421
2022
Q4 		$1.38M Buy
46,433
+41,679
+877% +$1.49M 0.02% 764
2022
Q3 		$181K Sell
4,754
-4,417
-48% -$221K ﹤0.01% 2404
2022
Q2 		$500K Sell
9,171
-3,221
-26% -$177K 0.01% 1956
2022
Q1 		$773K Sell
12,392
-8,414
-40% -$554K 0.01% 1604
2021
Q4 		$2.09M Sell
20,806
-2,745
-12% -$241K 0.01% 1045
2021
Q3 		$2.12M Buy
+23,551
New +$2.14M 0.01% 1215
2021
Q2 		– Sell
-3,109
Closed -$300K – 2974
2021
Q1 		$300K Sell
3,109
-2,542
-45% -$262K ﹤0.01% 2379
2020
Q4 		$294K Buy
+5,651
New +$236K ﹤0.01% 2383

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities's FLGT Position: Q2 2026 in Review

SG Americas Securities sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 18,356 shares — an estimated $292K sold.

SG Americas Securities first reported a position in FLGT in Q4 2020 and held it in 20 quarters. The position peaked at $2.12M in Q3 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • SG Americas Securities reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 18,356 Fulgent Genetics shares in Q2 2026, an estimated $292K.
  • SG Americas Securities first reported a position in Fulgent Genetics in Q4 2020 and held it in 20 quarters.
  • SG Americas Securities's Fulgent Genetics position peaked at $2.12M in Q3 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.